ESMO 2025 Conference Review focus on Targeted and Emerging Therapies in NSCLC

Product Review – Abilify Asimtufii (Aripiprazole) Every Two Months Long-Acting Injection for the Treatment of Schizophrenia

Product Review – Transforming the treatment approach for tumours associated with von Hippel-Lindau disease

Genitourinary Cancer Research Review, Issue 26

Prostate Cancer Research Review, Issue 91

Dermatology Research Review Issue 123

Haematology Research Review, Issue 143

Obstetrics & Gynaecology Research Review Issue 19

Biologics Research Review Issue 96 – Dermatology focus

HIV Nurses Research Review Issue 4